November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Yelak Biru: Is myeloma science and clinical progress fast or slow?
Jul 3, 2024, 06:28

Yelak Biru: Is myeloma science and clinical progress fast or slow?

Yelak Biru, President and CEO at the International Myeloma Foundation, shared on X:

“Is myeloma science and clinical progress fast or slow? Or just intentional?

  • 2003/2006 – The 1st Bortezomib and Lenalidomide received FDA approval (L1 and L2)
  • 2015 – SWOG S0777 published RVd as SOC for NDMM (L3)
  • 2024 – 4 drug combo may become SOC for NDMM (non-frail) (L4)”

Source: Yelak Biru/X